Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Cancer Research and Treatment|July 21, 2023
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH TrialKyoo Hyun Kim, Sun Min Lim, Hee Kyung Ahn, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 17, 2014
Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancerHee Kyung Ahn, Minkyu Jung, Seung-Yeon Ha, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2013
A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancerYoung Saing Kim, Sun Jin Sym, Se Hoon Park, et al.
American Journal of Clinical Oncology|January 6, 2022
Efficacy and Safety of Trastuzumab Biosimilar (CT-P6) Compared With Reference Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer: A Retrospective AnalysisJoo-Hwan Park, Ja Hyun Yeo, Young Saing Kim, et al.
Head & Neck|January 13, 2026
Exploratory Biomarker Analysis of Abemaciclib in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Dysregulated CDK4/6 PathwayJoo-Hwan Park, Hee Kyung Ahn, Hye Ryun Kim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2012
Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphomaJunshik Hong, Ji Yeon Kim, Hee Kyung Ahn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2013
Successful treatment with crizotinib in mechanically ventilated patients with ALK positive non-small-cell lung cancerHee Kyung Ahn, Kyeongman Jeon, Hongseok Yoo, et al.
The EMBO Journal|December 29, 2022
Sensor NLR immune proteins activate oligomerization of their NRC helpers in response to plant pathogensMauricio P Contreras, Hsuan Pai, Yasin Tumtas, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 11, 2010
Clinical presentation of carcinoma of unknown primary: 14 years of experienceJun Ho Yi, Yoon La Choi, Su Jin Lee, et al.
Cancer|October 27, 2021
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11)Hongsik Kim, Dong-Wan Kim, Miso Kim, et al.
Pageof 16